drugset / Trial / NCT00772603
Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Evaluation of the safety and efficacy of Oxcarbazepine XR as adjunctive treatment for adults with partial onset seizures
Timeline
- Start
- 2008-11
- Primary completion
- 2010-04
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxcarbazepine | Small molecule | 1200 mg | Oral |
| Comparator | Oxcarbazepine | Small molecule | 2400 mg | Oral |